s6y
Company name or ticker
Search
Adaptimmune Therapeutics PLC
425
TCR2 Therapeutics Inc.: Merger communication
Filed
Tuesday, May 30, 2023
Accession number
0001104659-23-066058
Documents
Merger communication
425
On sec.gov
Filing index
All files
Complete submission text
SGML header